...BRCA2 that restore the wild-type BRCA2 reading frame. First, in a cisplatin-resistant BRCA2-mutated breast-cancer cell l...
...BRCA2-deficient cells with these revertant BRCA2 alleles rescued PARP inhibitor sensitivity and HR deficiency. Most of t...
...BRCA2 germline mutations present. Methylation levels were tested by several quantitative techniques including MethyLight...
...BRCA2 mutations. Despite 17% to 39% of all BRCA mutation carriers having a mutation in BRCA2, no prospective study to da...
Women with BRCA1 or BRCA2 (BRCA1/2) mutations can reduce cancer incidence and mortality by using bilateral prophylactic ...
...BRCA2 mutations in 19 subjects (14.1%). Subjects were classified into five groups and 22 subgroups according to their pe...
...BRCA2, D2, E, F, G, I, J/BRIP1, L, M and N/PALB2). Previous studies of cancer incidence in relatives of Fanconi anemia c...
...BRCA2) with familial breast cancer who had been treated with 20-mg tamoxifen following surgery.,Eight (7%) individuals h...
...BRCA2-mediated DNA double-strand break repair and intra-S phase DNA damage checkpoint control, and its mutations are mod...
...BRCA2 gene mutation carriage was not carried out and more recently follow-up oocyte donation options are being considere...
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
